ArticleEcancermedicalscience2025
Text messaging to improve uptake of human papillomavirus vaccination: a study among adolescent girls living with HIV in Kisumu county.
Article in Ecancermedicalscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Despite the availability of human papillomavirus (HPV) vaccine, its uptake remains sub-optimal across all the eligible age groups in sub-Saharan Africa countries. The vaccine hesitancy is driven partly by a lack of information regarding the safety and efficacy of the HPV vaccine. This study evaluated the use of text messaging to improve HPV vaccine uptake in most at-risk population of adolescent girls living with HIV. Methodology: We enrolled 152 vaccine naïve adolescent girls and randomised them to either an intervention or a control arm. The intervention arm received weekly messages containing information about cervical cancer, HPV and HPV vaccination. The participants were follow-up for 6 months, with their vaccination status recorded at every clinic visit. The difference in the vaccination rates between the intervention and the control arms of the study was analysed using t-test to determine statistical significance. Results: Of the 151 participants who completed the study, 35 (23.2%) received the first dose of the HPV vaccine by the time the study closed at 6 months. Among these, 9 (25.7%) were respondents in the control arm and 26 (74.3%) in the intervention arm. This difference in HPV vaccine uptake was statistically significant Conclusion: The use of short text messaging services is a viable communication channel for sharing information about HPV and HPV vaccination with both parents and adolescent girls. This approach has the potential to improve uptake of HPV vaccination.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.